PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
15-Mar-2022 Nosopharm signs partnership with INRAE and University of Montpellier to develop new anti-infectives Andrew Lloyd Associates
14-Mar-2022 SeaBeLife receives close to €1.4M deep tech financing from Bpifrance  Andrew Lloyd Associates
11-Mar-2022 HOFSETH BIOCARE AWARDED BEST SUSTAINABLE BIOTECH COMPANY 2022 ACCOLADE HOFSETH BIOCARE
11-Mar-2022 Freeline Announces $26.1 Million Registered Direct Offering of American Depositary Shares Freeline Therapeutics
11-Mar-2022 Novavax Announces Launch of Global Vaccine Education Programs Novavax
10-Mar-2022 Scenic Biotech Announces $31 Million Financing to Progress Pipeline of Genetic Modifiers in Cancer and Rare Diseases Scenic Biotech
10-Mar-2022 Domain Therapeutics and Explicyte enter partnership agreement in immuno-oncology Andrew Lloyd Associates
10-Mar-2022 Scenic Biotech Announces $31 Million Financing to Progress Pipeline of Genetic Modifiers in Cancer and Rare Diseases Scenic Biotech
10-Mar-2022 Transgene and BioInvent Announce Poster Presentation on BT-001, a Novel Antibody-encoding Oncolytic Virus, at AACR 2022 Transgene
08-Mar-2022 Rapid Microbial Methods, Contamination Control, Sterility Assurance and Environmental Monitoring to be covered at Microbiology East Coast Conference in Boston SMi Group
08-Mar-2022 Vygon acquires Macatt Medica, Peruvian distributor of single-use medical devices Andrew Lloyd Associates
08-Mar-2022 Alfa Chemistry Materials Presents Itself as a New Supplier of Biomaterials Alfa Chemistry
07-Mar-2022 Scintil Photonics unveils its III-V-Augmented Silicon Photonic IC at OFC 2022  Andrew Lloyd Associates
07-Mar-2022 Tollys and Gustave Roussy enter into new research agreement Andrew Lloyd Associates
05-Mar-2022 Exclusive Chemaxon Interview released - Sponsor at AI in Drug Discovery Conference 2022 SMi Group
03-Mar-2022 Priothera – FDA and EMA Grant Orphan Drug Designation to mocravimod for the treatment of Acute Myeloid Leukemia (AML) in patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) Priothera
03-Mar-2022 CD Formulation: A Supplier of Binder Excipients for Pharmaceutical Preparation CD Formulation
02-Mar-2022 Oculis Strengthens Leading Ophthalmology Pipeline by In-Licensing Neuroprotective Drug Candidate for Glaucoma from Accure Therapeutics Andrew Lloyd Associates
02-Mar-2022 Actigen Initiates a Development Programme in Rare Disease MPS II Actigen
02-Mar-2022 Avance Clinical Announces New Office Opening in Sydney Avance Clinical